Birth prevalence of congenital heart disease

Epidemiology

Volumn 21, Issue 2, 2010, Pages 275-277

  Dolk, Helen ^a   Loane, Maria A ^a   Abramsky, Lenore ^b   De Walle, Hermien ^c   Garne, Ester ^d  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b EALING HOSPITAL NHS TRUST   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Hospital Liuebaelt   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CANADA; CONGENITAL HEART DISEASE; DATA ANALYSIS; EUROPE; FETUS DEATH; FETUS MALFORMATION; HUMAN; IRELAND; LETTER; LIVE BIRTH; NEURAL TUBE DEFECT; PREGNANCY TERMINATION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED KINGDOM; VITAMIN SUPPLEMENTATION;

ABORTION, LEGAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; PREGNANCY; PREVALENCE; QUEBEC;

EID: 77249146487     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181c2979b     Document Type: Letter

References (4)

1. Prsa M, Saroli T, Mackie AS, Dancea AD, Correa JA, Asgharian M. Birth prevalence of congenital heart disease. Epidemiology. 2009; 20:466-468.
2. EUROCAT Special Report: Congenital Heart Defects in Europe, 2000-2005. Available at: http://www.eurocat.ulster.ac.uk/pdf/ML/Reports/ EUROCAT-Special-Report-CHD.pdf. 2009.
3. Busby A, Abramsky L, Dolk H, Armstrong B, a EUROCAT Folic Acid Working Group. Preventing neural tube defects in Europe: population based study. BMJ. 2005;330:574-575. (Pubitemid 40380352)
4. EUROCAT Special Report: Survey of Folic Acid Policy and Practice in European Countries. 2007. Available at: http://www.eurocat.ulster.ac.uk/ pubdata/Folic-Acid.html#December%202007.